Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Evaluation of the Correlation Between Cd44, Tumor Prognosis and the 5-Year Survival Rate in Patients With Oral Tongue Scc



Kaboodkhani R1 ; Karimi E2 ; Ashtiani MTK2 ; Kowkabi S3 ; Firouzifar MR4 ; Yazdani F5 ; Yazdani N2
Authors

Source: Iranian Journal of Otorhinolaryngology Published:2016

Abstract

Introduction: 90% of the tumors in the head and neck are squamous-cell carcinomas (HNSCC), which have overall 5- year survival rate between 50% -60%. CD44 has been shown to be associated with the prognosis. Materials and Methods: Biopsy specimens of 51 patients with oral tongue SCC were evaluated by Immunohistochemistry (IHC) for the CD44 antibody. Results: There was no significant correlation between CD44 and survival (P=0.77), age (P=0.4), CD44 and lymph node metastasis (P=0.87), sex (P=0.947), smoking (P=0.287) and tumor size (P=0.813). However, there was significant correlation between smoking and survival. Conclusion: There are widespread discrepancies among the findings in the literature regarding the prognosis of CD44 expression in OCSCC. Our study shows that the expression of CD44 is not a marker of aggressive behavior in oral tongue SCC. Consequently, CD44 cannot be considered as handy tool to establish the tumor behavior, prognosis and 5- year survival rate of these tumors. © 2016 Mashhad University of Medical Sciences. All rights reserved.
Other Related Docs
7. Prevalence of Submandibular Gland Involvement in Neck Dissection Specimens of Patients With Oral Cavity Carcinoma, American Journal of Otolaryngology - Head and Neck Medicine and Surgery (2022)
9. Prognostic Significance of Cancer Stem Cell Markers in Patients With Salivary Gland Carcinomas, Applied Immunohistochemistry and Molecular Morphology (2022)
13. Oral Cancer: A Multicenter Study, Medicina Oral Patologia Oral y Cirugia Bucal (2018)
17. Oral Squamous Cell Carcinoma: The Role of Birc6 Serum Level, BioMed Research International (2022)